EPICEL (CULTURED EPIDERMAL AUTOGRAFTS) GRAFT UNK

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05,07 report with the FDA on 2012-11-01 for EPICEL (CULTURED EPIDERMAL AUTOGRAFTS) GRAFT UNK manufactured by Genzyme Biosurgery (cambridge).

Event Text Entries

[3080137] Epicel heat sealer deviation, graft dishes leakage [device malfunction]. A (b)(6) female, initials (b)(6), with 90% burns, received epicel (lot ee01624) cea graft on (b)(6) 2012. At the surgical procedure site, it was observed that the epicel transport unit with 40 grafts contained transport media which was concluded to have leaked from the graft dishes. According to the mfr medical science liaison, all the epicel grafts looked fine at time of procedure. There were no visible signs of epicel graft deterioration or contamination. The decision was made that the grafts were fit for use. The percent take for all applied pt epicel grafts was described as 80%, which is within statistical norm. At the time of this report, the pt is doing very well with excellent graft uptake. Potential serious risks to patient were identified as cell viability (potential graft failure) and sterility (potential breach). Description of the critical deviation: epicel grafts are packaged in polystyrene dishes in sterile transport media (dmem). The dishes are heat sealed with a foil lid. The foil lid is heat sealed in place using a heat sealing apparatus. Recently the epicel transport dishes were approved for a new foil lid. (s12 (b)(6) 2012). The epicel dishes are placed in a transport unit (metal container) and hand carried to the treatment site. On (b)(6) 2012, a product complaint was received by our internal customer service department via email from the genzyme medical science liaison (msl) present at the surgery for epicel patient lot ee01624. Upon receipt of the grafts, the msl observed approximately 20mls of transport media in the transport unit. The msl concluded that some of the graft dishes must have leaked, however, he could not identify which graft dishes the media had come from or how many of the dishes had leaked. During the grafting procedure it was noted by the msl that the surgeon felt the foil lid was easier than usual to peel off. The new foil lid should require more effort to remove than the previous foil lid. Catsweb record (b)(4) indicates from the msl that all 40 grafts received were used during the surgery for patient (b)(6). During batch record review for patient (b)(6) no deviations were noted. However, as part of the complaint investigation, it was noted by mfg management on (b)(4) 2012 that the heat sealer used during the subsequent epicel grafting for epicel patient lot ee01624 on (b)(6) 2012 was not operating as intended. Five out of forty-nine grafts were sealed using the unit in question for lot ee01612. The five grafts passed qc inspection prior to release. This was the same heat sealer used in the preparation of the grafts for patient lot ee01624. The malfunctioning heat sealer was removed from service. A second heat sealer was used to complete the mfr of the remaining 44 grafts for patient ee01612. All grafts passed qc inspection and all grafts shipped were utilized during surgery for patient (b)(6). There were no associated with this patient's graft. On (b)(6) 2012 a deviation dr# (b)(4), was initiated for heat sealer id number: (b)(4) for not operating as expected during the grafting of epicel patient lot ee01612.
Patient Sequence No: 1, Text Type: D, B5


[10267582] Conclusion: biosurgery conducted a robust in depth deviation investigation into this event. The root cause was determined and multiple corrective actions were identified. A review for previous occurrences of a malfunctioning heat sealer indicated that this was the first occurrence of this type of event and no trend was identified. Based on the findings there were no further actions required other than the capas that have been initiated. Mfr? S comment: the benefit-risk profile of the product is not affected by this report.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1226230-2012-00007
MDR Report Key2835216
Report Source05,07
Date Received2012-11-01
Date of Report2012-10-12
Date of Event2012-08-14
Date Mfgr Received2012-10-12
Date Added to Maude2013-02-07
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactBRUNO MENDEZ
Manufacturer Street675 WEST KENDALL STREET
Manufacturer CityCAMBRIDGE MA 02142
Manufacturer CountryUS
Manufacturer Postal02142
Manufacturer Phone6177686173
Manufacturer G1GENZYME BIOSURGERY
Manufacturer Street64 SIDNEY ST.
Manufacturer CityCAMBRIDGE MA 02139413
Manufacturer CountryUS
Manufacturer Postal Code02139 4136
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameEPICEL (CULTURED EPIDERMAL AUTOGRAFTS) GRAFT
Generic NameCULTURED EPIDERMAL AUTOGRAFTS
Product CodeOCE
Date Received2012-11-01
Model NumberUNK
Catalog NumberUNK
Lot NumberEE01624
ID NumberUNK
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerGENZYME BIOSURGERY (CAMBRIDGE)
Manufacturer Address64 SIDNEY ST. CAMBRIDGE MA 02139413 US 02139 4136


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2012-11-01

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.